These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 34076991)
1. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2. Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y J BUON; 2021; 26(2):444-449. PubMed ID: 34076991 [TBL] [Abstract][Full Text] [Related]
2. METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m Hu S; Song Y; Zhou Y; Jiao Y; Li G J Healthc Eng; 2022; 2022():5794422. PubMed ID: 35392146 [TBL] [Abstract][Full Text] [Related]
3. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1. Ma XX; Cao ZG; Zhao SL Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830 [TBL] [Abstract][Full Text] [Related]
4. The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA. Yu X; Zhao H; Cao Z Minerva Med; 2022 Apr; 113(2):309-314. PubMed ID: 32512975 [TBL] [Abstract][Full Text] [Related]
5. METTL3 facilitates tumor progression via an m Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592 [TBL] [Abstract][Full Text] [Related]
6. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms. He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192 [TBL] [Abstract][Full Text] [Related]
7. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2. Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970 [TBL] [Abstract][Full Text] [Related]
8. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS. Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869 [TBL] [Abstract][Full Text] [Related]
9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis. Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899 [TBL] [Abstract][Full Text] [Related]
10. METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2. Wang Y; Yang Z Brain Behav; 2023 May; 13(5):e2936. PubMed ID: 36977205 [TBL] [Abstract][Full Text] [Related]
11. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3. Yi J; Peng F; Zhao J; Gong X Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232 [TBL] [Abstract][Full Text] [Related]
12. Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m Wang K; Jiang L; Zhang Y; Chen C Onco Targets Ther; 2020; 13():1605-1612. PubMed ID: 32158230 [TBL] [Abstract][Full Text] [Related]
13. METTL3-mediated m6A modification of EPPK1 to promote the development of esophageal cancer through regulating the PI3K/AKT pathway. Jia J; Yu L Environ Toxicol; 2024 May; 39(5):2830-2841. PubMed ID: 38293837 [TBL] [Abstract][Full Text] [Related]
14. Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA. Chen WW; Qi JW; Hang Y; Wu JX; Zhou XX; Chen JZ; Wang J; Wang HH Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4263-4270. PubMed ID: 32373962 [TBL] [Abstract][Full Text] [Related]
15. Essential role of METTL3-mediated m Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227 [TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Wang H; Xu B; Shi J Gene; 2020 Jan; 722():144076. PubMed ID: 31454538 [TBL] [Abstract][Full Text] [Related]
17. Effect of m6A methyltransferase METTL3 -mediated MALAT1/E2F1/AGR2 axis on adriamycin resistance in breast cancer. Li S; Jiang F; Chen F; Deng Y; Pan X J Biochem Mol Toxicol; 2022 Jan; 36(1):e22922. PubMed ID: 34964205 [TBL] [Abstract][Full Text] [Related]
18. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
19. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis. Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593 [TBL] [Abstract][Full Text] [Related]
20. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP. Ma Z; Li Q; Liu P; Dong W; Zuo Y Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]